Stocksigma LogoStocksigma Logo

Sudarshan Pharma Migrates to NSE Main Board Effective 27th Oct'26

Sudarshan Pharma Industries has received approval from the National Stock Exchange of India (NSE) to list its equity shares on the Main Board (Capital

Sudarshan Pharma Migrates to NSE Main Board Effective 27th Oct'26

Sudarshan Pharma Industries Ltd 路 Others (Uncategorized) 路 23 Oct 2026, 11:55 pm

Sudarshan Pharma Migrates to NSE Main Board Effective 27th Oct'26 Sudarshan Pharma Industries has received approval from the National Stock Exchange of India (NSE) to list its equity shares on the Main Board (Capital Market Segment), effective 27th Oct'26, migrating from the BSE SME platform. A total of 254,470,600 fully paid-up equity shares of Re. 1/- each will trade under the symbol SUDARSHAN in the EQ series with a market lot of one share. Of the total equity capital, 117,244,110 shares are free from lock-in, while the remaining shares are locked in until Dec'27 and Feb'28.

Original exchange filing (PDF)

More announcements from Sudarshan Pharma Industries Ltd

All Sudarshan Pharma Industries Ltd announcements